Savers Value Village (SVV) Officer Executes Option Exercise and 10b5-1 Sale

Rhea-AI Filing Summary

Insider transactions by Melinda L. Geisser at Savers Value Village, Inc. (SVV). On 09/26/2025 the reporting person exercised options and sold shares under a pre-existing plan. She exercised options to acquire 20,000 shares at an exercise price of $1.41 per share, and on the same date sold 20,000 common shares pursuant to a 10b5-1 plan for a weighted-average sale price of $13.6923 per share (sales executed in a range of $13.48–$13.87). After these transactions the Form 4 reports 488,373 shares underlying previously granted options as beneficially owned (direct).

The Form 4 notes the exercised options were from the 2019 Management Incentive Plan, with the June 12, 2019 grant fully vested by March 28, 2024, and describes the composition of remaining options as ~22% time‑based and ~78% performance‑based.

Positive

• Exercise and sale disclosed transparently, including exercise price ($1.41) and weighted average sale price ($13.6923)
• Sale executed under a documented 10b5-1 plan, indicating pre-arranged trading
• Large remaining option position disclosed (488,373 shares underlying options) with vesting composition described

Negative

• Officer sold 20,000 shares, which reduces her immediately held common stock by that amount
• Majority of remaining options are performance‑based (approximately 78%), tying future ownership to performance conditions

Insights

Securities Analyst

TL;DR: Officer exercised options for 20,000 shares and sold 20,000 shares under a 10b5-1 plan; substantial option holdings remain.

The officer executed an option exercise at $1.41 and contemporaneously sold the same number of shares under a 10b5-1 plan at a weighted average of $13.6923, realizing the spread between exercise price and sale proceeds on the executed lots. The filing confirms that the June 12, 2019 option grant is fully vested and that a large majority of remaining options are performance‑based, which may affect future dilution depending on whether performance conditions are met. All statements are drawn from the Form 4 text.

Corporate Governance Expert

TL;DR: Transactions follow standard insider exercise/sale procedures and were executed pursuant to an established 10b5-1 plan.

The sale was executed under a 10b5-1 trading plan adopted March 10, 2025, as disclosed. The filing identifies the reporting person as Chief People Services Officer and shows proper disclosure of exercise, sale, vesting schedule, and the nature of remaining options (time‑based vs performance‑based). The Form 4 is procedural in nature and contains standard explanatory remarks without additional corporate governance exceptions noted.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Geisser Melinda L.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Services Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/26/2025		M		20,000	A	$1.41	20,000	D
Common Stock	09/26/2025		S(1)		20,000	D	$13.6923(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(3)	$1.41	09/26/2025		M			20,000	(4)	06/12/2029	Common Stock	20,000	$1.41	488,373(5)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $13.48 to $13.87. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

4. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

5. Approximately 22% represents time-based options which vested in substantially equal annual installments over 5 years starting March 28, 2020 and approximately 78% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway, attorney in fact	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Melinda L. Geisser report on Form 4 for SVV?

The Form 4 reports an exercise of options to acquire 20,000 shares at $1.41 per share on 09/26/2025 and a sale of 20,000 shares under a 10b5-1 plan at a weighted average price of $13.6923 per share.

How many shares does the filing report as beneficially owned after these transactions?

The filing reports 488,373 shares underlying options as beneficially owned (direct) following the reported transactions.

Were the shares sold under a pre-arranged plan?

Yes. The sale of 20,000 shares was made pursuant to a 10b5-1 plan adopted by the reporting person on March 10, 2025.

What is the origin and vesting status of the exercised options?

The exercised options were granted under the Registrant's 2019 Management Incentive Plan; the June 12, 2019 grant vested in equal annual installments over five years and was fully vested on March 28, 2024.

What portion of remaining options are performance‑based versus time‑based?

The filing states approximately 22% of remaining options are time‑based and approximately 78% are performance‑based, with 25% of performance options vesting upon the IPO and the rest contingent on performance criteria.